Akanda Corp. Common Shares

AKAN

Akanda Corp. is a biotech company focused on developing and commercializing innovative cannabinoid-based therapeutics. It aims to address unmet needs in healthcare by leveraging its expertise in drug development and formulations related to the cannabis industry.

$1.57 +0.22 (16.43%)
🚫 Akanda Corp. Common Shares does not pay dividends

Company News

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga • Avi Kapoor • April 11, 2024

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents...

3 Steps to Building a Profitable Penny Stocks Plan
PennyStocks • J Dylan • March 29, 2024

Here's 3 steps for building a profitable penny stocks trading plan in 2024 The post 3 Steps to Building a Profitable Penny Stocks Plan appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga • Avi Kapoor • March 28, 2024

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share. Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday. Here a...

Nasdaq Turns Higher; Akanda Shares Plunge
Benzinga • Avi Kapoor • March 25, 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also fell, dropping, 0.12% to 5,227.95. Check This Out: Progress Software Likely To Report Lower Q1 Earnings; Here Are The Recent Forecast Changes Fro...

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga • Avi Kapoor • March 25, 2024

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) and Landos Biopharma, reported a definitive agreement under which AbbVie will acquire Landos. Landos Biopharma shares jumped 171.2% to $21.70 on Monday. Here are some other stocks moving in today's mid-day s...

Related Companies